Literature DB >> 30411461

Oncological outcomes before and after the extralevator abdominoperineal excision era in rectal cancer patients treated with abdominoperineal excision in a single centre, high volume unit.

T Lehtonen1, M Räsänen2, M Carpelan-Holmström3, A Lepistö3.   

Abstract

AIM: The extralevator abdominoperineal excision (ELAPE) has been expected to reduce the risk of positive circumferential resection margins (CRMs) and local recurrence in locally advanced distal rectal cancer. The aim was to determine whether there is any difference in local recurrence rates between patients who were operated on for distal rectal cancer before and after the introduction of ELAPE in our unit. PATIENTS AND METHODS: In all, 206 patients with distal rectal cancer without distant metastases (T1-4N0-2M0) were treated with curative intent. The patients were divided into two cohorts operated in 2000-2007 (A) and 2008-2014 (B). The ELAPE procedure was introduced in 2008. Since then, it has been used in cases of T4 and T3 tumours with threatened margins. In T1-T3 tumours without threatened margins a conventional abdominal perineal excision has been performed.
RESULTS: There was no significant difference in overall survival or cancer-specific survival between the two time periods. The local recurrence rate was 15.5% in group A and 6.7% in group B (P = 0.048), although there was no significant difference in the cumulative local recurrence rate. Intra-operative tumour perforation occurred significantly more often during the earlier period when ELAPE was not in use: group A 15/71 (21.1%) vs group B 11/135 (8.1%), P = 0.01. CRM was positive more often in group A (16.4%) vs group B (7.4%), P = 0.054.
CONCLUSION: The local recurrence rate, intra-operative tumour perforation and positive CRM rate were significantly lower during the later period when more extensive surgery (ELAPE) was performed for locally advanced T3-T4 rectal cancer with threatened margins. Colorectal Disease
© 2018 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  ELAPE; rectal cancer

Mesh:

Year:  2019        PMID: 30411461     DOI: 10.1111/codi.14468

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  4 in total

Review 1.  Extralevator abdominoperineal excision for advanced low rectal cancer: Where to go.

Authors:  Yu Tao; Jia-Gang Han; Zhen-Jun Wang
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

2.  Long-term outcomes after extra-levator versus conventional abdominoperineal excision for low rectal cancer.

Authors:  Haoyu Zhang; Ganbin Li; Ke Cao; Zhiwei Zhai; Guanghui Wei; Chunxiang Ye; Baocheng Zhao; Zhenjun Wang; Jiagang Han
Journal:  BMC Surg       Date:  2022-06-22       Impact factor: 2.030

3.  Long-term outcomes of laparoscopic Extralevator Abdominoperineal excision with modified position change for low rectal Cancer treatment.

Authors:  Shaowei Sun; Shengbo Sun; Xiangyun Zheng; Jiangtao Yu; Wenchang Wang; Qing Gong; Guowei Zhao; Jing Li; Huanhu Zhang
Journal:  BMC Cancer       Date:  2022-08-24       Impact factor: 4.638

4.  A National Survey on Perineal Reconstruction Following Standard and Extralevator Abdominoperineal Excision: Current Practices and Trends in the UK.

Authors:  Rushabh Shah; Rituja Kamble; Mohammed Herieka; Milind Dalal
Journal:  Cureus       Date:  2022-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.